Profile
Elad Amor is currently the Chief Accounting Officer at Motus GI Holdings, Inc. He previously worked as the Director-Accounting & Section Reporting at Kaleido Biosciences, Inc. and as the Manager-SEC Reporting & Technical Accounting at CRISPR Therapeutics AG.
Elad has a graduate degree in Business Administration from Northeastern University and an undergraduate degree from the University of Wisconsin.
He also has a graduate degree from The Medical College of Wisconsin, Inc.
Elad Amor active positions
| Companies | Position | Start |
|---|---|---|
| MOTUS GI HOLDINGS, INC. | Comptroller/Controller/Auditor | 01/01/2019 |
Former positions of Elad Amor
| Companies | Position | End |
|---|---|---|
| CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 01/01/2019 |
| KALEIDO BIOSCIENCES, INC. | Comptroller/Controller/Auditor | - |
Training of Elad Amor
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Medical College of Wisconsin, Inc.
The Medical College of Wisconsin, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Motus GI Holdings, Inc.
Motus GI Holdings, Inc. Medical SpecialtiesHealth Technology Develops and supplies pure-vu systems | Health Technology |
- Stock Market
- Insiders
- Elad Amor
















